Andrew Scanga

2.4k total citations
19 papers, 683 citations indexed

About

Andrew Scanga is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Andrew Scanga has authored 19 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 11 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Andrew Scanga's work include Liver Disease Diagnosis and Treatment (10 papers), Liver Disease and Transplantation (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Andrew Scanga is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Liver Disease and Transplantation (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Andrew Scanga collaborates with scholars based in United States, Australia and Japan. Andrew Scanga's co-authors include Richard A. Rippe, Shimon Reif, Yutaka Yata, David A. Brenner, Erwin Gäbele, Alon Lang, Michael Breindl, Liu Yang, Kris V. Kowdley and Julia Wattacheril and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.

In The Last Decade

Andrew Scanga

18 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Scanga United States 10 383 295 175 156 65 19 683
Motonobu Watanabe Japan 16 397 1.0× 306 1.0× 298 1.7× 223 1.4× 57 0.9× 22 809
Aysha Ali United Kingdom 5 354 0.9× 353 1.2× 157 0.9× 176 1.1× 70 1.1× 13 845
Haruhiko Ozaki Japan 8 440 1.1× 203 0.7× 261 1.5× 125 0.8× 93 1.4× 16 709
Vikas Sud United States 7 135 0.4× 319 1.1× 115 0.7× 138 0.9× 42 0.6× 10 765
Carolina Jiménez Calvente United States 4 283 0.7× 410 1.4× 100 0.6× 406 2.6× 53 0.8× 7 801
A. M. James Shapiro Canada 17 583 1.5× 343 1.2× 879 5.0× 146 0.9× 58 0.9× 33 1.3k
Brigitta Globke Germany 12 148 0.4× 86 0.3× 203 1.2× 132 0.8× 54 0.8× 42 514
Yuki Ohya Japan 14 222 0.6× 105 0.4× 253 1.4× 161 1.0× 49 0.8× 50 504
Shigenari Hozawa Japan 11 159 0.4× 159 0.5× 167 1.0× 299 1.9× 148 2.3× 18 714
Kei Furui Japan 9 309 0.8× 215 0.7× 87 0.5× 150 1.0× 21 0.3× 11 649

Countries citing papers authored by Andrew Scanga

Since Specialization
Citations

This map shows the geographic impact of Andrew Scanga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Scanga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Scanga more than expected).

Fields of papers citing papers by Andrew Scanga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Scanga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Scanga. The network helps show where Andrew Scanga may publish in the future.

Co-authorship network of co-authors of Andrew Scanga

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Scanga. A scholar is included among the top collaborators of Andrew Scanga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Scanga. Andrew Scanga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Basile, Anna O., Anurag Verma, Marina Serper, et al.. (2024). Rapid identification and phenotyping of nonalcoholic fatty liver disease patients using a machine‐based approach in diverse healthcare systems. Clinical and Translational Science. 18(1). e70105–e70105. 2 indexed citations
2.
3.
Trinh, Vincent Quoc‐Huy, et al.. (2021). An Anomalous Cause of Portal Hypertension. ACG Case Reports Journal. 8(4). e00552–e00552. 1 indexed citations
4.
Phipps, Meaghan, Alexandra E. Livanos, Lara Dakhoul, et al.. (2020). Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United States. The American Journal of Gastroenterology. 115(9). 1486–1495. 28 indexed citations
5.
deLemos, Andrew S., Milin Patel, Samer Gawrieh, et al.. (2020). Distinctive Features and Outcomes of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Disease: A US Multicenter Study. Clinical and Translational Gastroenterology. 11(3). e00139–e00139. 4 indexed citations
6.
Abu‐Sbeih, Hamzah, Meaghan Phipps, Alexandra E. Livanos, et al.. (2020). Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort. Hepatology Communications. 4(11). 1708–1716. 18 indexed citations
7.
Shinall, Myrick C., Mohana Karlekar, Sara Martin, et al.. (2019). COMPASS: A Pilot Trial of an Early Palliative Care Intervention for Patients With End-Stage Liver Disease. Journal of Pain and Symptom Management. 58(4). 614–622.e3. 44 indexed citations
8.
Clark, Daniel E., Shi Huang, Roman Perri, et al.. (2019). More than the heart: Hepatic, renal, and cardiac dysfunction in adult Fontan patients. Congenital Heart Disease. 14(5). 765–771. 14 indexed citations
9.
Gawrieh, Samer, Lara Dakhoul, Ethan Miller, et al.. (2019). Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study. Alimentary Pharmacology & Therapeutics. 50(7). 809–821. 84 indexed citations
10.
Huh, Won Jae, et al.. (2019). 2357 Drug-Induced Liver Injury (DILI) Does Not Always Follow the Textbook. The American Journal of Gastroenterology. 114(1). S1312–S1313.
11.
Miller, E., Lara Dakhoul, Emily Mao, et al.. (2018). Increasing trend for Hepatocellular Carcinoma (HCC) linked to Nonalcoholic Fatty Liver Disease (NAFLD) in the United States. Journal of Hepatology. 68. S822–S822. 2 indexed citations
12.
deLemos, Andrew S., Lara Dakhoul, Patrick C. Roche, et al.. (2018). Nonalcoholic fatty liver disease is the most common cause of hepatocellular carcinoma (HCC) in individuals without cirrhosis: A United States multicenter study. Journal of Hepatology. 68. S419–S420. 2 indexed citations
13.
Corey, Kathleen E., Samer Gawrieh, Andrew S. deLemos, et al.. (2017). Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study. World Journal of Hepatology. 9(7). 385–385. 14 indexed citations
14.
Schneider, Nina, Andrew Scanga, LeAnn S. Stokes, & Roman Perri. (2011). Portal Vein Stenosis: A Rare Yet Clinically Important Cause of Delayed-onset Ascites after Adult Deceased Donor Liver Transplantation: Two Case Reports. Transplantation Proceedings. 43(10). 3829–3834. 25 indexed citations
15.
Yata, Yutaka, Feng Xue, Terumi Takahara, et al.. (2010). Docetaxel inhibits progression of human hepatoma cell line in vitro and is effective in advanced hepatocellular carcinoma. Hepatology Research. 40(3). 304–310. 3 indexed citations
16.
Scanga, Andrew & Kris V. Kowdley. (2007). Management of biliary complications following orthotopic liver transplantation. Current Gastroenterology Reports. 9(1). 31–38. 33 indexed citations
17.
Reif, Shimon, Alon Lang, Yutaka Yata, et al.. (2003). The Role of Focal Adhesion Kinase-Phosphatidylinositol 3-Kinase-Akt Signaling in Hepatic Stellate Cell Proliferation and Type I Collagen Expression. Journal of Biological Chemistry. 278(10). 8083–8090. 251 indexed citations
18.
Yata, Yutaka, Andrew Scanga, Liu Yang, et al.. (2003). DNase I-hypersensitive sites enhance α1(I) collagen gene expression in hepatic stellate cells. Hepatology. 37(2). 267–276. 154 indexed citations
19.
Reif, Shimon, Andrew Scanga, David A. Brenner, & Richard A. Rippe. (2001). The role of AKT in hepatic stellate cell activation. Gastroenterology. 120(5). A27–A27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Motonobu Watanabe Breakdown of academic impact, for papers by Aysha Ali Breakdown of academic impact, for papers by Haruhiko Ozaki Breakdown of academic impact, for papers by Vikas Sud Breakdown of academic impact, for papers by Carolina Jiménez Calvente Breakdown of academic impact, for papers by A. M. James Shapiro Breakdown of academic impact, for papers by Brigitta Globke Breakdown of academic impact, for papers by Yuki Ohya Breakdown of academic impact, for papers by Shigenari Hozawa Breakdown of academic impact, for papers by Kei Furui
Rankless by CCL
2026